טוען...
Twelve- and 52-week safety of albuterol multidose dry powder inhaler in patients with persistent asthma
Objective: Evaluate the safety of albuterol multidose dry powder inhaler (MDPI), a novel, inhalation-driven device that does not require coordination of actuation with inhalation, in patients with persistent asthma. Methods: We report pooled safety data from two 12-week, multicenter, randomized, dou...
שמור ב:
| הוצא לאור ב: | J Asthma |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Taylor & Francis
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4819808/ https://ncbi.nlm.nih.gov/pubmed/26369589 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/02770903.2015.1070862 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|